R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalisation model.

[1]  U. Lepola,et al.  Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care. , 2003 .

[2]  C. Sánchez,et al.  Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities , 2003, Psychopharmacology.

[3]  C. Sánchez.  Stress-induced vocalisation in adult animals. A valid model of anxiety? , 2003, European journal of pharmacology.

[4]  C. Sánchez,et al.  Escitalopram: A comparative in vitro study of 5-HT uptake inhibition and binding in a COS-1 cell line expressing the human 5-HT transporter , 2002, European Neuropsychopharmacology.

[5]  Jack M Gorman,et al.  Efficacy Comparison of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: Pooled Analysis of Placebo-Controlled Trials , 2002, CNS Spectrums.

[6]  W. Burke,et al.  Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. , 2002, The Journal of clinical psychiatry.

[7]  C. Nemeroff,et al.  Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine , 2001, Biological Psychiatry.

[8]  M. Papp,et al.  Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model. , 2001, Pharmacology & toxicology.

[9]  C. Sánchez,et al.  Assessment of relative efficacies of 5-HT1A receptor ligands by means of in vivo animal models. , 1996, European journal of pharmacology.

[10]  J. Vry,et al.  Somatodendritic 5-HT1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT , 1996, Psychopharmacology.

[11]  C. Sánchez,et al.  Effect of serotonergic drugs on footshock‐induced ultrasonic vocalization in adult male rats , 1993, Behavioural pharmacology.

[12]  P. Plenge,et al.  Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets. , 1991, European journal of pharmacology.

[13]  P. Plenge,et al.  Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes. , 1985, European journal of pharmacology.

[14]  K. Bogeso,et al.  The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer , 2005, Journal of Neural Transmission / General Section JNT.